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One possible interesting way of designing a scaffold for bone tissue engineering is to base
it on trying to mimic the biophysical structure of natural extracellular matrix (ECM). This
work was developed in order to produce scaffolds for supporting bone cells. Nano and
micro fiber combined scaffolds were originally produced from starch based biomaterials by
means of a fiber bonding and a electrospinning, two step methodology. The cell culture
studies with SaOs-2 human osteoblast-like cell line and rat bone marrow stromal cells
demonstrated that presence of nanofibers influenced cell shape and cytoskeletal
organization of the cells on the nano/micro combined scaffolds. Moreover, cell viability and
Alkaline Phosphatase (ALP) activity for both cell types was found to be higher in nano/micro
combined scaffolds than in control scaffolds based on fiber meshes without nanofibers.
Consequently, the developed structures are believed have a great potential on the 3D
organization and guidance of cells that is provided for engineering of 3-dimensional bone
tissues.
C© 2005 Springer Science + Business Media, Inc.
1. Introduction
Bone tissue engineering has become a rapidly
expanding research area since it offers a new and
promising approach for bone repair and regeneration.
Several requirements have been considered for engi-
neering bone, including choosing a cell type that ma-
tures/differentiates into bone cells with the proper form
and phenotype, regulating the growth factors and de-
signing a so-called ideal scaffold [1]. The require-
ments for the design and production of an ideal scaf-
fold are also very complex and not yet fully under-
stood. An ideal scaffold must be biocompatible both
in bulk and degraded form, exhibit a porous, intercon-
nected, and permeable structure to permit the ingress
of cells and nutrients, and should exhibit the appro-
priate surface structure and chemistry for cell adhe-
sion and proliferation. The processing techniques used
to obtain polymeric scaffolds include solvent cast-
ing and particulate leaching, gas foaming, freeze dry-
ing, rapid prototyping, thermally induce phase sepa-
rating, fiber bonding, melt molding and electrospin-
ning, as reviewed elsewhere [2]. Several techniques
aim to produce a scaffold which can mimic in some
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way the architecture of the natural extracellular matrix
(ECM).
Natural extracellular matrix (ECM) is composed of
various protein fibrils and fibers interwoven within a hy-
drated network of glycosaminoglycan chains [3]. This
network structure serves as a scaffold which can support
tensile and compressive stresses by the fibrils and hy-
drated networks. Besides providing an appropriate mi-
croenvironment for cells, ECM is responsible for trans-
mitting signals to cell membrane receptors that reach
nucleus via intracellular signaling cascades. Therefore,
the fibrillar and porous structure of ECM have a great
influence on cell functionality, mainly on cell adhesion
and migration.
In last few years, the electrospinning processes have
attracted a great deal of attention as a way to try to
mimic the structure of natural ECM by means of pro-
ducing fibers down to 3 nm [4]. This process is based
on the generation of an electrical field between a poly-
meric solution (or a polymer melt) placed in a capillary
tube with a pipette or needle of small diameter and a
metal collector. When the electrical field reaches its crit-
ical value, repulsive electrostatic force overcomes the
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surface tension of the polymeric solution and a charged
jet is produced. This charged polymeric jet then un-
dergoes a stretching process which is accompanied by
the rapid solvent evaporation and results the formation
of long and thin fibers [5]. Electrospinning has been
used to fabricate nanofibrous structures from a num-
ber of both natural synthetic polymers, such as col-
lagen [6], chitosan [7] chitin [8], silk fibroin [9]) and
polyethyleneoxide [10], poly(DL-lactide-co-glycolide)
[11], poly(L-lactide) [12], and polycaprolactone [13],
among many others. The produced nanofibrous poly-
meric networks have been proposed for engineering
of many different tissues. For instance, Li et al. [14]
reported that electrospun poly(ε-caprolactone) mem-
branes could promote chondrocyte proliferation and
provide maintenance of chondrogenic phenotype. In
another study, polyurethane and gelatin have been used
to design a mesoscopically ordered structure for using
as an artificial graft [15]. Recently, it has been shown
that nanofibrous PCL mats could be used as a scaffold
to support differentiation of human mesenchymal stem
cell cultured in specific differentiation media [16]. Silk
fibroin based nanofibrous matrices have also been tested
with human bone marrow stromal cells and proposed
as a scaffold for bone tissue engineering [17].
Though there are many studies that have been
proposing nanofibrous polymeric mats for tissue en-
gineering, they have a limitation for 3D applications
due to their pore size which is smaller than a cellular
diameter and can not allow cell migration within the
structure. Furthermore, the small size of the fibers tends
not to maximize the points of cell attachment which is a
negative effect on the expression of several factors and
on cell spreading and differentiation.
In the present study, we have developed a novel
structure which combines polymeric micro and
nanofibers in the same construct that is aimed to serve
as a scaffold and mimic the physical structure of ECM
for bone tissue regeneration, but simultaneously still
providing the macro support that cells do require.
2. Materials and methods
2.1. Materials
Starch-based scaffolds with a 70% porosity were
prepared from a blend of starch/poycaprolactone
(SPCL) (30/70 wt%) by a fiber bonding process as
described elsewhere [18]. All the reagents used were
analytical grade unless specified otherwise.
2.2. Electrospinning process
Electrospinning was used to obtain nanofibers onto
SPCL fiber mesh scaffolds. The aim was to impreg-
nate, as much as possible, the micro-fiber scaffolds
with electrospun nanofibers. The solution used in
the electrospinning experiments was prepared by dis-
solving 1 g of SPCL in 7 ml chloroform. After dis-
solution was completed, 3 ml of dimethylformamide
(DMF) which has a high dielectric constant was added
to the solution to enhance electrospinning of the
solution.
The polymer solution was then electrospun to the
both side of the SPCL fiber mesh scaffolds. Briefly, a
polymer solution was placed in a simple capillary glass
tube vertically. A special designed collector was used to
move samples through the electrospun polymeric jets.
A 15 kV voltage was provided by a high power supply at
a distance of 10 cm between a collector and a capillary
tube for 10 s.
2.2.1. Morphological analysis
The developed structures were analyzed by optical mi-
croscopy (Olympus, MIC-D). To observe more detail in
morphology of the nanofibers on the scaffolds, a scan-
ning electron microscope (SEM) (Leica Cambridge
S360 microscope) was also used.
2.3. Cell culture
The developed structures were tested with two different
cell type, a human osteoblast-like osteosarcoma SaOs-2
cell line and rat bone marrow stromal cells. In both ex-
periment sets SPCL fiber mesh scaffolds without elec-
trospun nanofibers were used as controls.
In the cell culture experiments with a human
osteoblast-like SaOs-2 cell line, cells were seeded onto
the scaffold using a density of 3× 105 cells/scaffolds
and allowed to grow for two weeks, with medium
(DMEM low glucose supplemented with 10% Foetal
Bovine Serum, 1% antibiotics/antimicotics changes ev-
ery 2 days.
Rat bone marrow stromal cells (RBMSC) were
obtained from the femoras and tibias of 4 weeks-
old male Wistar rats (Charles River, Spain) as de-
scribed elsewhere [19]. Briefly, femurs and tibias
were aseptically excised, cleaned of soft tissue, and
washed in α-MEM (Life Technologies, Grand Is-
land, NY) containing 10 times more amount of nor-
mal antibiotics concentration in order to avoid con-
tamination during the harvest. Then, the epiphyses
were cut off, and the diaphyses flushed with 5 ml
of complete medium [α-MEM (minimal essential
medium); Eagle, Sigma, St. Louis, MO], supplemented
with 10% FBS (foetal bovine serum; Biochrome),
50µg/mL ascorbic acid (Sigma), 50µg/mL gen-
tamycin, 100µg/mL ampicillin, 0.3µg/mL fungizone,
10 mM β-glycerophosphate (Sigma), and 10−8 M dex-
amethasone (Sigma)]. Cells were cultured at 37 ◦C in
a humidified atmosphere containing 5% of CO2.
The confluent cell monolayers were detached using
trypsin/EDTA (0.25% tyripsin/0.02% EDTA, Sigma)
and resuspended in complete medium. A 50µl of cell
suspension containing 3× 105 cells were pippeted onto
the each scaffold. Cell/scaffold constructs were incu-
bated at 37 ◦C for 2 h to allow RBMSC to diffuse into
and adhere to the scaffolds before adding 1 ml of cul-
ture medium to each well. The cells on the scaffolds
were then allowed to grown for 2 weeks at 37 ◦C in
a humidified atmosphere containing 5% of CO2 with
medium changes every 2–3 days.
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2.3.1. Morphological analysis
After 7 and 14 days of culture, cell/scaffold constructs
were fixed in 2.5% glutaraldehyde, dehydrated through
graded series of ethanol and dried. The samples were
mounted onto brass stubs, sputter coated with cold and
analyzed under a Scanning Electron Microscope (SEM)
at an accelerating voltage 15 kV.
2.3.2. Cell proliferation assay
After 7 and 14 days of culture, cell viability was as-
sessed by using Cell Titer 96©R Aqueous One Solution
Cell proliferation Assay kit (Promega, USA). This test
is based on the bioreduction of the substrate, (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2(4-sulfophenyl)-2H tetrazolium) (MTS), into a brown
formazan product by NADPH or NADP produced
by dehydrogenase enzymes in metabolically active
cells. For this assay, culture medium was removed,
samples were washed with PBS before the addition of
serum free medium plus Cell Titer 96©R Aqueous One
Solution (5/1 ratio). The samples were then incubated
for three hours at 37 ◦C in a humidified atmosphere
containing 5% of CO2. A 100µl of incubated medium
was transferred to 96-well plate culture plate and the
optical density was read at 490 nm in a micro-plate
reader (Synergy HT, Bio-tek).
2.3.3. Alkaline phosphatase (ALP) activity
Alkaline phosphatase (ALP) activity from the scaf-
folds/ cells constructs was quantified by the specific
conversion of p-nitrophenyl phosphate (pNPP) into p-
nitrophenol (pNP). The enzyme reaction was carried
out at 37 ◦C for 1 h and then stopped by a solution
containing 2 M NaOH and 0.2 mM EDTA in distilled
water. The absorbance of p-nitrophenol formed was de-
termined at 405 nm with a reference filter at 620 nm. A
standard curve was made using pNP values ranging
from 0 to 600µmol/ml. The results were expressed as
µmol of pNP produced/ml/h. Please note that ALP ac-
tivity was determined in weekly collected supernatant
and lysed cell for SAOS-2 and RBMSC, respectively.
3. Results & discussion
3.1. Nano- and micro fiber combined
scaffolds
Fig. 1(a) presents the images of the newly designed
combined nano/micro fiber structures. As it can be seen,
nanofibers could be randomly electrospun on the mi-
crofibers and they present the structure that looks like
a nanobridge between the microfibers which is very
similar to the architecture of ECM [20]. The average
diameter of produced SPCL nanofiber was measured
to be around 400nm (Fig. 1(b)). Moreover, nanofibers
presented a fine morphology without presence of beads
which is refered as a common problem of electropsun
fibers [4]. These results also confirmed that the process-
ing parameters were successfully optimized in order to
produce fine nanofibers from SPCL.
Figure 1 Microscopic images of the scaffolds. (B) presents a detailed
view of nanofibers as observed by SEM.
3.2. Cell culture
3.2.1. Morphological Analysis
Regarding cell culture studies with SaOs-2 and
RBMSC, cell responses in both cases were clearly dif-
ferent to the nano/micro fiber combined scaffolds when
directly compared with the control fiber mesh scaffolds.
It was observed that there were significant differences,
mainly those related with cell shape and morphology,
which could indicate that the patterned layered by the
nanofibers was leading to a different cytoskeleton re-
arrangement on the seeded cells. SEM images showed
that cells had covered microfibers and started to fill
the spaces between the latter using for that purpose the
previously laid down nanofibers after 7 days of culture.
Fig. 2 shows confluent growth on combined scaffolds
and control by the SaOs-2 osteoblast-like cell line. As
it can be observed the cell population growing on the
combined scaffolds presented a different organization
being able to bridge between microfibers. The presence
of nanofibers also led to the changes in cell morphology
(Fig. 2(c) and (d)). Cells along the nanofibers showed
very stretched morhologhy. This fact can be particu-
lar useful as this cytoskeletal rearrangement could af-
fect gene expression, as described by a report of Curtis
and Wilkonson [21]. It has been claimed that when the
cells stretch themselves, the receptors are also stretched
and activated. This results on the expression of differ-
ent genes than those observed in unstretched cells. This
particular hypothesis will be further confirmed in forth-
coming (already ongoing) studies. A similar cell re-
sponse was observed in the study with RBMSC (Fig. 3).
After 14 days of culture, the scaffolds were covered
by cells which used nanofibers to bridge between mi-
crofibers (Fig. 3(b) and (c)).
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Figure 2 Human osteoblast like cells (SAOS-2) seeded on nano-
and micro-fiber combined scaffolds and control (scaffolds without
nanofibers); (A) after 7 days, (B), (C) and (D) after 14 days of cul-
ture.E) Human osteoblast like cells on control scaffolds after 14 days of
culture. (Continued)
Figure 2 (Continued)
It is known that human cells can attach and organize
themselves well around the fibers diameter smaller than
those of the cells [22]. This approach might explain the
behavior of the cells on the developed combined scaf-
folds. This cell organization could provide better and
faster colonization of the scaffolds with cells which is
of main importance for tissue engineering approaches.
3.2.2. Cell viability
The effect of nano/micro fiber combination on cell
viability and proliferation of both cell types was tested
using a MTS assay. The MTS assay is based on a re-
duction reaction which reduced MTS reagent to brown
formazan product when incubated with viable cells.
Thus, the absorbance of formazan indirectly reflected
the metabolic activity of cells, which is also associated
with cell number. Figs. 4 and 5 present the MTS results
of cell culture studies with SAOS-2 and BMSC, respec-
tively. After 7 and 14 days of culturing O.D. values
were found to be considerably different for combined
scaffolds in both studies. These results indicate that
both cell types seeded on combined scaffolds showed
increasing metabolic activity and growth rates when di-
rectly compared with the control. This fact is closely
related with the previously deposited nanofiber mesh.
While reducing large void spaces between the pores
the mesh is creating additional structures where cells
can adhere from the very beginning, avoiding at the
same time that the cell suspension drops through the
pores until it reaches the bottom of the wells. This par-
ticular phenomena shows the validity of the proposed
methodology for increasing the cell seeding and cultur-
ing conditions during the development of bone tissue
engineered constructs.
3.2.3. ALP activity
ALP is a well-known enzyme used as a marker of the
osteogenic phenotype, which catalyzes the hydrolysis
of phosphate esters at an alkaline pH [23]. The skele-
tal isoform of ALP is a glycoprotein found on the cell
membrane of osteoblasts [24]. It has been also demon-
strated that it plays an important role in bone matrix
mineralization process.
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Figure 3 Rat bone marrow stromal cells (RBMSC) seeded on nano-
and micro-fiber combined scaffolds and control (scaffolds without
nanofibers); (A) after 7 days, (B) and (C) after 14 days of culture.
(D) Rat bone marrow stromal cells on control scaffolds after 7 days of
culture.
Figure 4 Cell viability and proliferation of human osteoblast like cells
determined by MTS. Error bars represent means ± SD for n = 3.
Figure 5 Cell viability and proliferation of rat bone marrow stromal
cells determined by MTS. Error bars represent means ± SD for n = 3.
Figure 6 The ALP activity of human osteoblast like cells seeded on
SPCL nano- and micro-fiber combined scaffolds and control (scaffolds
without nanofibers). Error bars represent means ± SD for n = 3.
Figs. 6 and 7 shows the ALP activity of SaOs-2 and
RBMSC cultured on the combined scaffolds and con-
trol scaffolds. In both cases, the enzyme activity of
scaffolds with nano fibers was higher than that of con-
trol in the end of first week. In the case of RBMSC,
the differences in enzyme activity became even higher
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Figure 7 The ALP activity of rat bone marrow stromal cells seeded on
SPCL nano- and micro-fiber combined scaffolds and control (scaffolds
without nanofibers). Error bars represent means ± SD for n = 3.
after a second week of culture. This is probably related
with the different proliferation rates of the cells seeded
on the different scaffolds and at the same time with a
probable more induced osteogenic phenotype. The lat-
ter hypothesis might be related with the cytoskeleton
rearrengment caused by the nanofibers. However fur-
ther studies are needed to evaluate the influence of these
structures on the differentiation of osteogenic celss.
4. Conclusions
An electrospinning technique was used to produce
nanofibers on SPCL fiber meshes in order to combine
nano- and microfibers in the same 3D scaffold archi-
tecture. It was clearly demonstrated that cell response
changed completely with the addition of nanofibers
on the fiber meshes. Osteoblasts were organized to
bridge between microfibers and this resulted in scaf-
folds completely filled with cells after two weeks of
culture. Moreover, the presence of nanofibers had an
influence in cell morphology which was observed to be
much more streched and spread. The scaffolds without
nanofibers did not show this kind of organization and
the morphology of cells remained normal, and form-
ing a continuous cell monolayer over microfibers. Fur-
thermore, cells seeeded on combined scaffolds showed
higher viability and ALP activity than that on control.
The results from this study indicate that nano- and
micro-fiber scaffolds can provide an ideal structure
for cell deposition and organization. Their unique
architecture which supports and guides the cells makes
them a suitable candidate for bone tissue engineering
applications
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